Citation 35754

BRYANT,ML: HEUCKEROTH,RO: KIMATA,JT: RATNER,L: GORDON,JI:. (1989). REPLICATION OF HUMAN IMMUNODEFICIENCY VIRUS 1 AND MOLONEY MURINE LEUKEMIA VIRUS IS INHIBITED BY DIFFERENT HETEROATOM-CONTAINING ANALOGS OF MYRISTIC ACID.. 86(11)

Citation Details

Title	REPLICATION OF HUMAN IMMUNODEFICIENCY VIRUS 1 AND MOLONEY MURINE LEUKEMIA VIRUS IS INHIBITED BY DIFFERENT HETEROATOM-CONTAINING ANALOGS OF MYRISTIC ACID.
Authors	BRYANT,ML: HEUCKEROTH,RO: KIMATA,JT: RATNER,L: GORDON,JI:
Year	1989
Volume	86
Issue	11

Summary

Year: 1989

Journal: Unknown

Organisms and Their Experiments (3)

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	ANTIVIRAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	MYRISTIC ACID,6-OXA:*	ACTIVE
2	SYNCYTIA INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	MYRISTIC ACID,6-OXA:*	ACTIVE
3	ANTIVIRAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	MYRISTIC ACID,6-OXA:*	ACTIVE

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	ANTIVIRAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	MYRISTIC ACID,11-OXA:*	ACTIVE
2	SYNCYTIA INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	MYRISTIC ACID,11-OXA:*	ACTIVE

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	ANTIVIRAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	MYRISTIC ACID,13-OXA:*	ACTIVE
2	SYNCYTIA INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	MYRISTIC ACID,13-OXA:*	ACTIVE
3	REVERSE TRANSCRIPTASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	MYRISTIC ACID,13-OXA:*	ACTIVE
4	NEPHROTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	MYRISTIC ACID,13-OXA:*	INACTIVE

Citation 35754

Citation Details

Summary

Organisms and Their Experiments (3)

Unknown organism

Unknown organism

Unknown organism

Show SPARQL Queries (1)

Query 1